Table 2.
Result of meta-analysis of survival rate of breast cancer in EMRO base on each country and year of survival.
| Country | Survival rate by year | ||||||
|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 7 | 10 | |
| Bahrain | 84 (81.7–86.2) | NR | NR | NR | 64.5 (59.5–69.5) | 57.3 (48.5–66.1) | 45 (35.7–54.3) |
| Egypt | NR | NR | 96.4 (95.2–97.5) | NR | 91.4 (89.6–93.1) | NR | NR |
| Iran | 94 (92.4–95.6) | 88 (81.4–94.6) | 80.8 (77.5–84.1) | 74.8 (64.4–85) | 69 (64.5–73.4) | 79 (74.1–83.8) | 59.2 (49–69.4) |
| Jordan | 92.5 (91.1–93.9) | 81.6 (79.1–84.1) | 72.4 (68.4–76.4) | 67.5 (64.7–80.2) | 61.9 (57.1–66.7) | NR | NR |
| Kuwait | NR | NR | 83.2 (79.3–87) | NR | 78.3 (73–83.7) | NR | NR |
| Libya | NR | NR | NR | NR | 60.6 (53.2–68) | NR | NR |
| Morocco | 97.1 (95.7–98.4) | NR | 85 (76.6–93.4) | NR | 78.4 (74.2–82.7) | NR | NR |
| Oman | NR | NR | NR | NR | 72.5 (61.7–83.2) | NR | NR |
| Pakistan | NR | NR | NR | NR | 73.2 (69.7–76.7) | NR | 54 (51.2–56.8) |
| Saudi Arabia | NR | NR | NR | NR | 65.3 (58.4–72.1) | NR | 55 (49.5–60.5) |
| Tunisia | NR | 49.1 (31.1–67.1) | 33.7 (19.3–51.2) | NR | 51.5 (46.8–56.1) | 50 (46.4–53.6) | NR |
| Overall | 93.6 (92.3–95) | 85 (79.9–90) | 79.8 (76–83.7) | 72.6 (65–80.2) | 69.2 (66.5–72) | 62.1 (41.8–82.3) | 55.5 (49.3–61.8) |